An IgA blood test measures immunoglobulin A circulating in serum. In IgA vasculitis, the result may be elevated, but it is neither sensitive nor specific enough to diagnose the condition or predict kidney damage. IgA vasculitis is recognized mainly by its clinical pattern—typically non-blanching palpable purpura on the legs or buttocks, often with joint pain, abdominal symptoms, or kidney findings—and may be confirmed by a skin or kidney biopsy showing IgA-dominant deposits. The most important kidney-risk tests are not the serum IgA level. They are urinalysis, urine protein measurement, blood pressure, serum creatinine, and estimated glomerular filtration rate. Kidney involvement can initially be silent, so monitoring matters even when a person feels well and even when the serum IgA concentration is normal.
- High serum IgA can occur in IgA vasculitis, but it does not confirm the diagnosis.
- A normal IgA level does not rule IgA vasculitis out.
- Urine blood, urine protein, blood pressure, creatinine, and eGFR are the key kidney-risk measures.
- Kidney findings may appear after the rash begins and may cause no early symptoms.
- Adults generally have a greater risk of serious or persistent kidney disease than children.
Table of Contents
- What a Serum IgA Test Measures
- Why IgA May Be High in IgA Vasculitis
- How IgA Vasculitis Is Actually Diagnosed
- Tests That Reveal Kidney Risk
- Monitoring, Referral, and Kidney Biopsy
- How to Interpret Common Result Patterns
- Symptoms That Need Prompt Medical Care
What a Serum IgA Test Measures
Immunoglobulin A is an antibody class concentrated in mucosal areas such as the respiratory tract, gastrointestinal tract, and saliva. It helps defend surfaces that regularly encounter food proteins, microbes, and environmental material. A smaller amount circulates in blood, where a laboratory can measure the total serum IgA concentration.
The test reports a number, usually in milligrams per deciliter (mg/dL) or grams per liter (g/L). Reference intervals vary by laboratory, age, and method. Many adult laboratories use a range roughly around 70–400 mg/dL, but the range printed on the patient’s own report is the correct comparator. Children require age-specific ranges because IgA production increases through childhood.
Total serum IgA is not the same as the disease-causing material deposited in small blood vessels. IgA vasculitis involves IgA1-containing immune complexes and inflammation in vessel walls. A person can have abnormal IgA deposition while the total amount of IgA in serum remains within the laboratory interval. Conversely, a high serum value may reflect another process and not vasculitis.
The test is also different from an IgA subclass assay, a test for galactose-deficient IgA1 used mainly in research or selected specialty settings, and immunofixation testing for a monoclonal protein. A standard IgA blood test usually measures the total concentration only.
Serum IgA may be ordered as part of an immunoglobulin panel, a celiac disease evaluation, an infection or immune-deficiency workup, or a vasculitis assessment. In suspected IgA vasculitis, it provides supportive background information. It should never be treated as the decisive test.
Why IgA May Be High in IgA Vasculitis
A high IgA result means the measured concentration exceeds the laboratory’s reference interval. Some patients with IgA vasculitis have elevated serum IgA, reflecting increased production or altered handling of IgA-related immune material. However, studies find high levels in only a subset of patients. The proportion varies with age, timing, assay, and population.
The key limitation is specificity. Elevated IgA can occur with:
- Chronic liver disease, especially cirrhosis
- Persistent respiratory or gastrointestinal infection
- Other autoimmune or inflammatory diseases
- Inflammatory bowel disease
- Chronic lung disease
- Certain skin disorders
- Some blood-cell or plasma-cell disorders
- Polyclonal immune activation from several causes
A mildly high value therefore does not identify the source. The magnitude also does not map cleanly to disease severity. A patient with a modest elevation can have important kidney involvement, while another person with a much higher concentration may have no vasculitis at all.
When IgA is markedly elevated, clinicians may look at the full immunoglobulin pattern and serum protein electrophoresis or immunofixation. This helps distinguish broad, polyclonal immune activation from a monoclonal IgA protein produced by one abnormal cell clone. Monoclonal IgA can be associated with plasma-cell or lymphoid disorders and requires a different evaluation.
A normal result is equally limited. IgA vasculitis cannot be excluded because the disease is defined by tissue deposition and clinical manifestations, not by an excess of total circulating antibody. Normal serum IgA should not halt evaluation when the rash, abdominal symptoms, joints, urine, or biopsy findings point toward the diagnosis.
The serum value also is not a reliable monitoring target. It may remain high after symptoms improve, normalize despite ongoing kidney disease, or fluctuate for unrelated reasons. Serial IgA testing is generally less informative than serial urine and kidney-function testing.
Low rather than high IgA creates a different interpretive issue. Selective IgA deficiency can reduce the reliability of IgA-based tests used for other conditions, such as standard celiac serology, but it does not provide a simple explanation for purpura or nephritis. A low result may lead clinicians to review recurrent infections, medications, protein loss, and the other immunoglobulin classes. It should not be “corrected” into a vasculitis diagnosis based on symptoms alone.
How IgA Vasculitis Is Actually Diagnosed
IgA vasculitis, formerly called Henoch–Schönlein purpura, is a small-vessel vasculitis. It most often affects skin, joints, the gastrointestinal tract, and kidneys. Children are affected more commonly, often after an upper respiratory infection, but adults can develop the disease and may have more severe kidney outcomes.
The classic skin finding is palpable purpura: raised red-purple spots that do not fade when pressed. Lesions usually cluster on gravity-dependent areas such as the lower legs and buttocks, although adults may have wider distribution. Thrombocytopenia or a clotting disorder must not better explain the purpura.
Other common manifestations include:
- Ankle or knee pain and swelling
- Colicky abdominal pain
- Nausea, vomiting, or gastrointestinal bleeding
- Microscopic or visible blood in urine
- Protein in urine
- Swelling caused by protein loss or kidney dysfunction
- High blood pressure
Classification frameworks generally require purpura or petechiae with lower-limb predominance plus at least one additional feature, such as abdominal pain, arthritis or arthralgia, kidney involvement, or biopsy evidence of IgA-predominant deposits. These criteria help organize evidence but do not replace clinical judgment.
A skin biopsy is particularly helpful when the rash is atypical, occurs in an adult, or has a broad differential diagnosis. Routine microscopy may show leukocytoclastic vasculitis, and direct immunofluorescence can demonstrate IgA-dominant vascular deposits. The biopsy should ideally sample a fresh lesion because older lesions may lose diagnostic immune staining.
Blood tests help assess alternatives and complications. A complete blood count checks platelets, anemia, and white blood cells. CRP and ESR may show inflammation but are nonspecific. Complement levels are often normal; low complement can redirect attention toward immune-complex disorders such as lupus or cryoglobulinemic vasculitis. ANCA testing may be appropriate when the kidney or lung pattern raises concern for ANCA-associated vasculitis.
The diagnosis is sometimes less straightforward in adults. Infection, medication reactions, malignancy, liver disease, inflammatory bowel disease, and other systemic illnesses may trigger or mimic IgA-containing small-vessel vasculitis. The clinical team may investigate these possibilities according to age, history, examination, and laboratory findings.
Tests That Reveal Kidney Risk
Kidney involvement is the major determinant of long-term outcome. It may be present when the rash appears, emerge days or weeks later, or occasionally develop after other symptoms have improved. Because early kidney inflammation can be asymptomatic, screening should not rely on pain, swelling, or changes in urination.
The core kidney evaluation includes:
- Urinalysis: Detects blood and protein. Microscopic hematuria may be the first sign. Red blood cell casts or dysmorphic red cells suggest bleeding from the glomeruli.
- Urine protein measurement: A spot urine protein-to-creatinine ratio or albumin-to-creatinine ratio estimates daily protein loss. A dipstick is useful for screening but is less precise.
- Serum creatinine and eGFR: Show filtration function. A rising creatinine or falling eGFR is concerning, but creatinine can remain normal in early nephritis.
- Blood pressure: Hypertension can signal kidney involvement and can accelerate kidney injury.
- Serum albumin: A low result may reflect substantial urinary protein loss, inflammation, or gastrointestinal protein loss.
These tests answer different questions. Urine blood indicates glomerular injury, urine protein helps quantify risk, and creatinine estimates current kidney function. None can be replaced by serum IgA.
Persistent proteinuria is especially important. The amount and duration of protein loss, together with eGFR and blood pressure, guide nephrology referral and management. Current kidney guidance emphasizes reducing proteinuria and protecting remaining nephrons. Treatment may include blood-pressure control and renin–angiotensin system blockade when appropriate, while immunosuppression is reserved for selected forms of active or severe nephritis.
The distinction between IgA vasculitis nephritis and primary IgA nephropathy can be blurred at the kidney level because their biopsy findings and disease mechanisms overlap. IgA vasculitis includes systemic manifestations such as purpura, abdominal pain, or arthritis. IgA nephropathy primarily presents as kidney disease without the characteristic systemic vasculitic syndrome.
A single normal urinalysis at diagnosis is reassuring but not definitive. Follow-up urine and blood-pressure checks are needed because kidney findings can appear later. Exact schedules differ for children and adults and should be individualized, but monitoring is generally most frequent during the first weeks and months.
Monitoring, Referral, and Kidney Biopsy
Monitoring should continue after the rash fades. Clinicians typically repeat urinalysis and blood pressure at planned intervals and add creatinine, eGFR, and quantitative urine protein testing when abnormalities appear. Children with entirely normal kidney screening often need surveillance for several months. Adults generally merit a low threshold for closer follow-up because they are more likely to develop persistent nephritis, chronic kidney disease, or recurrence.
Nephrology referral is appropriate for findings such as:
- Persistent or increasing proteinuria
- Visible blood in urine that is not otherwise explained
- Rising creatinine or declining eGFR
- Hypertension
- Nephrotic syndrome, including heavy proteinuria, low serum albumin, and edema
- Red blood cell casts
- Rapidly progressive kidney dysfunction
- Diagnostic uncertainty or suspected overlapping glomerular disease
A kidney biopsy is not required for every patient. It becomes important when the result could change prognosis or treatment. Common reasons include substantial or persistent proteinuria, impaired kidney function, rapidly progressive glomerulonephritis, nephrotic syndrome, or an atypical presentation. The biopsy identifies the degree of glomerular inflammation, crescent formation, scarring, and IgA-dominant deposits.
Biopsy findings must be interpreted with the clinical course. Extensive active lesions may support immunosuppressive treatment in severe disease, while established fibrosis or tubular atrophy indicates chronic damage less likely to reverse. A biopsy is a risk-stratification tool, not simply a yes-or-no test.
Kidney-protective care matters even when systemic symptoms are mild. Blood pressure should be controlled, smoking avoided, and nonsteroidal anti-inflammatory drugs used cautiously or avoided when kidney disease, dehydration, or gastrointestinal bleeding is present. Medication doses may require adjustment for kidney function.
For people with known nephritis, follow-up extends beyond the initial vasculitis episode. Persistent microscopic blood alone has a different risk profile from ongoing proteinuria, hypertension, and reduced eGFR. The latter findings require long-term kidney surveillance.
How to Interpret Common Result Patterns
No laboratory value should be interpreted in isolation. The following patterns illustrate why:
| Result pattern | Likely meaning | Usual next focus |
|---|---|---|
| High serum IgA, typical purpura, normal urine | Supports immune activation but does not prove vasculitis or eliminate later kidney risk | Clinical diagnosis or skin biopsy when needed; repeat urine and blood pressure |
| Normal serum IgA, typical purpura and joint or abdominal symptoms | IgA vasculitis remains possible | Assess platelets, urine, blood pressure, kidney function, and consider biopsy |
| High serum IgA with blood and protein in urine | Could fit IgA vasculitis nephritis, but other liver, immune, or monoclonal causes remain possible | Quantify protein, check creatinine/eGFR, nephrology evaluation, consider biopsy |
| Normal serum IgA with rising creatinine and active urine sediment | Serious nephritis is possible despite normal total IgA | Urgent nephrology review and workup for IgA vasculitis and other glomerulonephritides |
| Isolated high IgA without rash or kidney findings | Usually does not indicate IgA vasculitis | Review liver disease, infection, inflammation, immunoglobulin pattern, and monoclonal protein risk |
The trend in urine protein, creatinine, and blood pressure is usually more clinically important than the trend in serum IgA. A person whose IgA concentration falls but proteinuria rises is not improving from a kidney perspective. Conversely, a persistently high IgA result does not necessarily mean treatment has failed if symptoms and organ findings have resolved.
Results should also be checked for unit differences. One gram per liter equals 100 mg/dL. Comparing values from different laboratories without converting units or checking reference intervals can create a false impression of change.
In children, age-specific immunoglobulin ranges are essential. A value that would be low for an adult may be expected in a young child, while an apparently modest elevation may be meaningful relative to the child’s range. The laboratory report should provide the appropriate interval.
Symptoms That Need Prompt Medical Care
Most childhood cases improve, but IgA vasculitis can cause urgent gastrointestinal, kidney, or other complications. Seek prompt medical evaluation for reduced urine output, visible blood in urine, new facial or leg swelling, shortness of breath, severe headache with high blood pressure, or rapidly increasing weight from fluid retention.
Severe or persistent abdominal pain, repeated vomiting, black stool, bloody stool, abdominal swelling, or marked tenderness also requires urgent assessment. Intestinal bleeding, bowel-wall swelling, intussusception in children, and less common ischemic complications may need imaging or surgical review.
Scrotal pain or swelling in a child should be evaluated urgently because vasculitic inflammation can resemble testicular torsion, which is a surgical emergency. New neurologic symptoms, chest pain, coughing blood, or breathing difficulty are uncommon but should not be attributed to a rash without assessment.
Patients should contact their clinician promptly if purpura recurs after apparent recovery or if a routine urine test becomes abnormal. Recurrence does not always mean severe disease, but it resets the need to check kidney status.
The most useful practical message is simple: serum IgA provides context, while urine, blood pressure, and kidney function determine kidney risk. A high number may attract attention, but silent proteinuria or a rising creatinine deserves more weight.
References
- IgA Nephropathy (IgAN) / IgA Vasculitis (IgAV). 2025. Kidney Disease: Improving Global Outcomes guideline resource.
- KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). 2025. Clinical practice guideline.
- IgA Vasculitis (Henoch–Schönlein Purpura): An Update on Treatment. 2024. Peer-reviewed review.
- Diagnostic and Management Strategies of IgA Vasculitis Nephritis/Henoch–Schönlein Purpura Nephritis in Pediatric Patients: Current Perspectives. 2023. Peer-reviewed review.
- Interventions for Preventing and Treating Kidney Disease in IgA Vasculitis. 2023. Cochrane systematic review.
- IgA Vasculitis With Nephritis: Update of Pathogenesis With Clinical Implications. 2021. Peer-reviewed review.
Disclaimer
This article is for educational purposes and does not replace medical diagnosis or treatment. Serum IgA and kidney tests must be interpreted with the rash, symptoms, examination, age, medications, and laboratory-specific ranges. Seek urgent care for reduced urine, swelling, severe abdominal symptoms, gastrointestinal bleeding, breathing difficulty, or neurologic changes.
